Fate Therapeutics, Inc. (FATE) Earnings
NASDAQ·Healthcare·Biotechnology
$2.45
-5.23%
Mkt Cap $294.89M
EPS — Estimate vs Actual
Mkt Cap
$294.89M
P/E
—
Fwd P/E
—
P/S
46.69
Rev TTM
—
EPS TTM
-$1.09
NASDAQ·Healthcare·Biotechnology
$2.45
-5.23%
Mkt Cap $294.89M
Mkt Cap
$294.89M
P/E
—
Fwd P/E
—
P/S
46.69
Rev TTM
—
EPS TTM
-$1.09